These results demonstrate that adiponectin across its full concentration range has significant effect on MetS risk and acts independently of the other MetS risk factors, whilst HOMA and trunk FFSTM only have independent effects at high levels. The gene discussed is ADIPOQ; the disease is metabolic syndrome.